SEC Form 4 · accession 0001209191-15-009394
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Sculley
Director
Period of report
Feb 3, 2015
Accepted (ET)
Feb 4, 2015 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 3, 2015 | C | 35,026 | $0.00 | A | 35,026 | I | Held by John and Diane Sculley, Tenants in the Entirety |
| Common StockF1 | Feb 3, 2015 | C | 19,376 | $0.00 | A | 54,402 | I | Held by John and Diane Sculley, Tenants in the Entirety |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF1,F2,F3 | $0.00 | Feb 3, 2015 | C | 150,000 | D | — | — | Common Stock | 150,000 | 0 | I |
| Series B Preferred StockF1,F2,F3 | $0.00 | Feb 3, 2015 | C | 82,978 | D | — | — | Common Stock | 82,978 | 0 | I |
Explanation of responses
- F1The shares automatically converted on a 4.2825-for-1 basis into shares of the Issuer's Common Stock upon the closing of a Qualified Public Offering (as defined in the Amended and Restated Certificate of Incorporation).
- F2N/A.
- F3The shares have no expiration date.